Linked Life Data

3480793

Source:http://linkedlifedata.com/resource/pubmed/id/3480793

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1988-3-10
pubmed:abstractText
Serum ovarian carcinoma antigen (CA 125) and carcinoembryonic antigen (CEA) were measured in 36 patients with ovarian cancer, to compare their effects and assess clinical applications. The positive rate of CA 125 was significantly higher than CEA, ie, 72.2% v.s. 33.3% in all types of ovarian cancer, 81.3% v.s. 31.3% in the 32 epithelial cancers, and even more of 100% v.s. 25% in the 16 serous cystadenocarcinoma. The positive rate of CA 125 was also higher than CEA in borderline malignancy and stage-I cancers, a possible indication of its greater usefulness in early diagnosis. CA 125 was also a better marker in monitoring of epithelial ovarian cancer than CEA. Combining use of these two markers achieved an even higher positive rate. Therefore it seems useful to utilize them concomitantly in the diagnosis of ovarian cancers.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0253-2662
pubmed:author
pubmed:issnType
Print
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
190-7
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1987
pubmed:articleTitle
Comparative measurement of ovarian carcinoma antigen and carcinoembryonic antigen in the serum of ovarian cancer.
pubmed:affiliation
Department of Obstetrics and Gynecology, Veterans General Hospital, Taipei, ROC.
pubmed:publicationType
Journal Article, Comparative Study